SCHEMBL47584

SCHEMBL47584

CC(C)(C)C(=N)C(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 1/20 0.32
ALDH1A1 P00352 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12673581 0.76
SCHEMBL24668147 0.76 NOS1 (0.32) NOS1ALDH1A1CYP3A4MAPTCYP2D6
SCHEMBL20226172 0.76 TSHR (0.33)
SCHEMBL10342426 0.70 NOS1 (0.32) NOS1ALDH1A1CYP3A4MAPTCYP2D6
SCHEMBL7029442 0.70
SCHEMBL20622172 0.67
SCHEMBL20282548 0.67
SCHEMBL803572 0.67
SCHEMBL12102191 0.67
Hydrochloric Acid SCHEMBL184285 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11371136-B2 Methods for selective deposition of dielectric on silicon oxide APPLIED MATERIALS, INC. (US) 2022-06-28 US claimed
US-20200216949-A1 Methods For Selective Deposition Of Dielectric On Silicon Oxide APPLIED MATERIALS, INC. 2020-07-09 US claimed
CN-111108232-A Method for selective deposition of dielectric on silicon dioxide 应用材料公司 2020-05-05 CN claimed
US-10340552-B1 Electrolyte composition and metal-ion battery employing the same INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2019-07-02 US claimed
US-20190198927-A1 ELECTROLYTE COMPOSITION AND METAL-ION BATTERY EMPLOYING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2019-06-27 US claimed
WO-2002046096-A1 METHOD FOR MAKING HYDRAZINE IN AQUEOUS SOLUTION FLUOROTECH, LLC (US) 2002-06-13 WO claimed
EP-4631934-A1 FLUORINE-CONTAINING ISOXAZOLE COMPOUND AND METHOD FOR PRODUCING SAME Unimatec Co., Ltd. (JP) 2025-10-15 EP disclosed
EP-3965738-B1 METHOD FOR PRODUCTION OF LIPOSOMES UNIV DO MINHO (PT) 2025-08-06 EP disclosed
WO-2024225214-A1 FLUORINE-CONTAINING ISOXAZOLONE COMPOUND AND PRODUCTION METHOD FOR SAME ユニマテック株式会社 2024-10-31 WO disclosed
WO-2024122444-A1 FLUORINE-CONTAINING ISOXAZOLE COMPOUND AND METHOD FOR PRODUCING SAME ユニマテック株式会社 2024-06-13 WO disclosed
US-20230312786-A1 PRODUCTION METHOD FOR CYCLIC OLEFIN COPOLYMER POLYPLASTICS CO., LTD. (JP) 2023-10-05 US disclosed
US-20230303619-A1 DEPROTECTION METHOD AND RESIN REMOVAL METHOD IN SOLID-PHASE REACTION FOR PEPTIDE COMPOUND OR AMIDE COMPOUND, AND METHOD FOR PRODUCING PEPTIDE COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-09-28 US disclosed
US-20230303619-A1 DEPROTECTION METHOD AND RESIN REMOVAL METHOD IN SOLID-PHASE REACTION FOR PEPTIDE COMPOUND OR AMIDE COMPOUND, AND METHOD FOR PRODUCING PEPTIDE COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-09-28 US disclosed
WO-2002046096-A1 METHOD FOR MAKING HYDRAZINE IN AQUEOUS SOLUTION FLUOROTECH, LLC (US) 2002-06-13 WO disclosed
US-4894464-A ARTIFICIAL SWEETENERS PFIZER INC. (US) 1990-01-16 US disclosed
US-4855454-A CHEMICAL INTERMEDIATES; SWEETENERS PFIZER INC. (US) 1989-08-08 US disclosed
US-4804782-A ARTIFICIAL SWEETENER PFIZER, INC. (US) 1989-02-14 US disclosed
EP-0034876-B1 BRANCHED AMIDES OF L-ASPARTYL-D-AMINO ACID DIPEPTIDES AND COMPOSITIONS THEREOF PFIZER INC. (US) 1984-08-29 EP disclosed
US-4411925-A STABLE SWEETENERS PFIZER INC. (US) 1983-10-25 US disclosed
EP-0034876-A2 Branched amides of L-aspartyl-D-amino acid dipeptides and compositions thereof PFIZER INC. (US) 1981-09-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303619-A1 DEPROTECTION METHOD AND RESIN REMOVAL METHOD IN SOLID-PHASE REACTION FOR PEPTIDE COMPOUND OR AMIDE COMPOUND, AND METHOD FOR PRODUCING PEPTIDE COMPOUND VIP, PEPD, MLN NOS1 2076/4885ALDH1A1 4602/4885CYP3A4 3792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.